By Mercy Kachenge
Nairobi, Kenya: The Pharmacy and Poisons Board (PPB) has issued a public alert regarding the voluntary recall of a specific batch of S-PRAZO (Esomeprazole Magnesium Delayed-Release Capsules 40mg), Batch No SPZ-302, manufactured by Laborate Pharmaceutical India Limited.
According to the Pharmacy and Poisons Board, the recall was prompted by a market complaint involving a mix-up of blister strips, where some boxes were found to contain two different blister strips—S-Prazo Capsules and Donystatin Tablets within the same outer carton.
S-PRAZO (Esomeprazole Magnesium Delayed-Release Capsules 40mg) is used primarily for the treatment of ulcers and acid-related conditions.
Dr. F. M. Siyoi, the Chief Executive Officer of the Pharmacy and Poisons Boardused primarily for the treatment of ulcers and acid-related conditions, following a packaging error that has raised serious concerns.
According to Dr. F. M. Siyoi, the Chief Executive Officer of the Pharmacy and Poisons Board, all pharmaceutical outlets, healthcare facilities, professionals, and members of the public are advised to immediately stop the distribution, sale, issuing, or use of the affected batch. He urged them to return the specified product batch to the nearest healthcare facility or respective suppliers.
Dr. Siyoi emphasized the importance of vigilance in ensuring the safety and efficacy of medicines distributed to the public, urging healthcare professionals to take immediate action in response to this recall.
The Board is asking for prompt reporting of any suspected cases of substandard medicines or adverse drug reactions. that can be made through the PPB’s website, mobile application, or via email and telephone as provided in the public notice.
